CRESY trades 19.4% below Wall Street's consensus target of $12.68.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CRESY achieves its forward estimates and maintains a stable P/E multiple of 0.1x. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESY) has a Wall Street consensus price target of $12.68, based on estimates from 1 covering analysts. With the stock currently trading at $10.62, this represents a potential upside of +19.4%. The company has a market capitalization of $689M.
Analyst price targets range from a low of $12.68 to a high of $12.68, representing a 0% spread in expectations. The median target of $12.68 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CRESY trades at a trailing P/E of 9999.0x and forward P/E of 0.1x. Analysts expect EPS to grow -94.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $141345.66, with bear and bull scenarios of $89047.77 and $186237.04 respectively. Model confidence stands at 41/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
AGROAdecoagro S.A. | $5.4B | $9.62 | $9.00 | -6.4% | Hold | 5.0x | 8 |
BIOXBioceres Crop Solutions Corp. | $21M | $0.33 | — | — | — | — | — |
VNETVNET Group, Inc. | $2.1B | $7.71 | $19.03 | +146.8% | Buy | — | 16 |
LNDBrasilAgro - Companhia Brasileira de Propriedades Agrícolas | $353M | $3.54 | — | — | — | — | — |
FPIFarmland Partners Inc. | $418M | $9.58 | $17.00 | +77.5% | Hold | 51.8x | 15 |
LANDGladstone Land Corporation | $369M | $8.56 | $13.33 | +55.7% | Buy | — | 11 |
ALCOAlico, Inc. | $312M | $42.03 | $45.00 | +7.1% | Buy | — | 3 |
VITLVital Farms, Inc. | $563M | $13.15 | $12.88 | -2.1% | Buy | — | 16 |
ADMArcher-Daniels-Midland Company | $37.7B | $78.20 | $75.25 | -3.8% | Hold | 16.8x | 36 |
BGBunge Global S.A. | $21.5B | $110.91 | $133.67 | +20.5% | Buy | 11.8x | 25 |
Quick answers to the most common questions about buying CRESY stock.
Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESY) has a consensus 12-month price target of $12.68, implying 19.4% upside from $10.62. The 1 analysts covering CRESY see moderate appreciation potential.
CRESY has a consensus rating of "Buy" based on 1 Wall Street analysts. The rating breakdown is predominantly bullish, with 1 Buy/Strong Buy ratings. The consensus 12-month price target of $12.68 implies 19.4% upside from current levels.
With a forward P/E of 0.0668x, CRESY trades at a relatively low valuation. The consensus target of $12.68 implies 19.4% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $12.6829 for CRESY, while the most conservative target is $12.6829. The consensus of $12.68 represents the median expectation. Our quantitative valuation model projects a bull case target of $186237 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CRESY is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CRESY stock forecast based on 1 Wall Street analysts shows a consensus price target of $12.68, with estimates ranging from $12.6829 (bear case) to $12.6829 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $141346, with bear/bull scenarios of $89048/$186237.
Our quantitative valuation model calculates CRESY's fair value at $141346 (base case), with a bear case of $89048 and bull case of $186237. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 41/100.
CRESY trades at a forward P/E ratio of 0.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 9999.0x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on CRESY, with a "Buy" consensus rating and $12.68 price target (19.4% upside). 1 of 1 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CRESY analyst price targets range from $12.6829 to $12.6829, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $12.68 consensus represents the middle ground. Our model's $89048-$186237 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.